Thomas Hazel is Vice President of Scientific Operations at BullFrog AI. He is responsible for building and scaling scientific teams, advancing platform-based drug discovery, and translating innovative science into clinical-stage programs. Previously, he was BullFrog’s Vice President of Drug Development for five years. Before joining the Company, Thomas was a Senior Vice President of Research & Development at Seneca Biopharma and Vice President of Research at Innovative Biosensors, Inc. He earned his B.A. in Biology from Kalamazoo College and his Ph.D. in Genetics from the University of Illinois College of Medicine.
